{
  "id": "icd11#screening_cues_c1fd468d",
  "title_en": "General — Screening Cues",
  "title_vi": "General — Dấu hiệu sàng lọc",
  "text_en": "important to rule out the possibility that a medication or substance is causing difficulties in the acquisition or execution of specific intellectual, motor or social functions instead of – or in addition to – an underlying medical condition. This involves first considering whether any of the medications being used to treat the medical condition are known to cause developmental difficulties at the dose and duration at which it has been administered. Second, a temporal relationship between the medication use and the onset of the developmental difficulties should be established (i.e. the developmental difficulties began after administration of the medication). Secondary mental or behavioural syndromes associated with disorders and diseases classified elsewhere 656 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders Potentially explanatory medical conditions (examples) Brain disorders and general medical conditions that have been shown to be capable of producing long-lasting intellectual impairment, poor social functioning, learning difficulties and disruptions in attentional processes include: • diseases of the nervous system (e.g. acquired epileptic aphasia (Landau-Kleffner syndrome), autoimmune encephalitis, encephalopathy); • developmental anomalies (e.g. Rett syndrome); • diseases of the visual system (e.g. congenital blindness, vision impairment); • endocrine, nutritional or metabolic diseases (e.g. diabetes mellitus, hyper- or hypothyroidism, Lesch-Nyhan syndrome, lysosomal diseases such as neuronal ceroid, lipofuscinosis or sphingolipidosis, mucolipidosis, phenylketonuria); • injury, poisoning or certain other consequences of external causes (e.g. brain injury, concussion, traumatic haemorrhage); • neoplasms (e.g. neoplasms of brain or meninges). Brain disorders and general medical conditions that have been shown to be capable of producing long-lasting movement dysfunction or motor impairment include: • diseases of the nervous system (e.g. cerebral palsy, Huntington disease, muscular dystrophy, Parkinson disease, tardive dyskinesia); • developmental anomalies (e.g. Ehlers-Danlos syndrome, Rett syndrome); • endocrine, nutritional or metabolic diseases (e.g. Lesch-Nyhan syndrome). 6E60.Z Secondary neurodevelopmental syndrome, unspecified 6E61 Secondary psychotic syndrome Essential (required) features • The presence of prominent hallucinations and/or delusions is required for diagnosis. • The symptoms are judged to be the direct pathophysiological consequence of a medical condition, based on evidence from the history, physical examination or laboratory findings. This judgement depends on establishing the following. • The medical condition is known to be capable of producing the symptoms. • The course of the hallucinations and/or delusions (e.g. onset, remission, response of the psychotic symptoms to treatment of the etiological medical condition) is consistent with causation by the medical condition. Secondary mental or behavioural syndromes associated with disorders and diseases classified elsewhere",
  "gloss_vi": "Important to rule out the possibility that a medication or substance is causing difficulties in the acquisition or execution of specific intellectual, motor or social functions instead of – or in addition to – an underly...",
  "source": "WHO ICD-11",
  "url": "https://icd.who.int/",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "screening_cues",
      "management"
    ],
    "life_topics": [
      "study",
      "relationships"
    ],
    "advice_section": [],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Screening Cues General — Dấu hiệu sàng lọc important to rule out the possibility that a medication or substance is causing difficulties in the acquisition or execution of specific intellectual, motor or social functions instead of – or in addition to – an underlying medical condition. This involves first considering whether any of the medications being used to treat the medical condition are known to cause developmental difficulties at the dose and duration at which it has been administered. Second, a temporal relationship between the medication use and the onset of the developmental difficulties should be established (i.e. the developmental difficulties began after administration of the medication). Secondary mental or behavioural syndromes associated with disorders and diseases classified elsewhere 656 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders Potentially explanatory medical conditions (examples) Brain disorders and general medical conditions that have been shown to be capable of producing long-lasting intellectual impairment, poor social functioning, learning difficulties and disruptions in attentional processes include: • diseases of the nervous system (e.g. acquired epileptic aphasia (Landau-Kleffner syndrome), autoimmune encephalitis, encephalopathy); • developmental anomalies (e.g. Rett syndrome); • diseases of the visual system (e.g. congenital blindness, vision impairment); • endocrine, nutritional or metabolic diseases (e.g. diabetes mellitus, hyper- or hypothyroidism, Lesch-Nyhan syndrome, lysosomal diseases such as neuronal ceroid, lipofuscinosis or sphingolipidosis, mucolipidosis, phenylketonuria); • injury, poisoning or certain other consequences of external causes (e.g. brain injury, concussion, traumatic haemorrhage); • neoplasms (e.g. neoplasms of brain or meninges). Brain disorders and general medical conditions that have been shown to be capable of producing long-lasting movement dysfunction or motor impairment include: • diseases of the nervous system (e.g. cerebral palsy, Huntington disease, muscular dystrophy, Parkinson disease, tardive dyskinesia); • developmental anomalies (e.g. Ehlers-Danlos syndrome, Rett syndrome); • endocrine, nutritional or metabolic diseases (e.g. Lesch-Nyhan syndrome). 6E60.Z Secondary neurodevelopmental syndrome, unspecified 6E61 Secondary psychotic syndrome Essential (required) features • The presence of prominent hallucinations and/or delusions is required for diagnosis. • The symptoms are judged to be the direct pathophysiological consequence of a medical condition, based on evidence from the history, physical examination or laboratory findings. This judgement depends on establishing the following. • The medical condition is known to be capable of producing the symptoms. • The course of the hallucinations and/or delusions (e.g. onset, remission, response of the psychotic symptoms to treatment of the etiological medical condition) is consistent with causation by the medical condition. Secondary mental or behavioural syndromes associated with disorders and diseases classified elsewhere Important to rule out the possibility that a medication or substance is causing difficulties in the acquisition or execution of specific intellectual, motor or social functions instead of – or in addition to – an underly..."
}